Claims
- 1. A medical device having battery end-of-service indication comprising:
- (a) an implantable housing;
- (b) a medical device within said implantable housing,
- (c) a cathode-limited electrochemical cell having an active metal anode and a manganese dioxide cathode within the housing;
- (d) analog voltage measurement means within the housing for measuring a voltage of the electrochemical cell;
- (e) analog-to-digital conversion means within the housing for converting the measured analog voltage into a digital signal; and
- (f) telemetry means within the housing for telemetry of the digital signal.
- 2. A medical device according to claim 1 wherein the active metal anode is lithium.
- 3. A medical device according to claim 2 wherein a capacity ratio of lithium anode to manganese dioxide in the cathode limited electrochemical cell is in a range of about 1.0 to about 1.5.
- 4. A medical device according to claim 1 wherein telemetry of the digital signal is accomplished by pulse position modulation.
- 5. A medical device according to claim 1 wherein telemetry of the digital signal includes means for multiple voltage data transmission and means for error detection.
- 6. A method for determining battery end-of-service for implantable medical device comprising:
- (a) providing a cathode limited electrochemical cell having an active metal anode and a manganese dioxide cathode in an implantable medical device;
- (b) measuring a voltage of the cathode limited electrochemical cell in analog form;
- (c) converting the analog voltage measurement into a digital signal; and
- (d) transmitting the digital signal from the implantable medical device.
- 7. A method according to claim 6 wherein the step of providing an electrochemical cell includes the step of providing a lithium anode.
- 8. A method according to claim 7 wherein the step of providing an electrochemical cell includes the step of providing lithium anode and manganese dioxide cathode in the electrochemical cell in a capacity ratio of lithium to manganese dioxide in the cell in a range of about 1.0 to about 1.5.
- 9. A method according to claim 6 wherein the step of transmitting of the digital signal is accomplished by pulse position modulation.
- 10. A method according to claim 6 wherein the step of transmitting the digital signal includes transmitting the digital signal at least twice with error detection comparison of the transmitted digital signals.
Parent Case Info
This application is a continuation-in-part of U.S. Ser. No. 07/896,641, filed Jun. 10, 1992, which is a continuation-in-part of U.S. Ser. No. 07/765,475, filed Sep. 25, 1991, now issued as U.S. Pat. No. 5,127,404, which is a continuation of U.S. Ser. No. 07/468,407, filed Jan. 22, 1990, now abandoned.
US Referenced Citations (10)
Continuations (1)
|
Number |
Date |
Country |
Parent |
468407 |
Jan 1990 |
|
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
896641 |
Jun 1992 |
|
Parent |
765475 |
Sep 1991 |
|